BGNE

BeiGene, Ltd. (BGNE)

Last Price$226.70.0%
Market Cap$1,846.9M
LTM Gross margin
83.1%
5Y avg
(74.6%)
Biotechnology industry median
66.6%
Stock quality & Intrinsic value
5/10
11.4% undervalued

BeiGene, Ltd. Gross margin

Annual
Quarterly
LTM
Industry median
Company stand-alone
BGNE
Healthcare
Crunching data... Almost there!
Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Gross margin
(20.8%)
(67.7%)
(560.7%)
(9,062.0%)
(14.9%)
(257.0%)
(133.2%)
(342.1%)
(38.1%)
(36.1%)
84.5%
BGNE
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for BGNE and see if it's the right time to invest.
Dive in

BeiGene, Ltd. (BGNE) Gross margin comparison analysis

Crunching data... Almost there!

BGNE key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is BeiGene, Ltd.'s Gross margin?

As of today, Microsoft Corp's last 12-month Gross margin is 83.1%, based on the financial report for Sep 30, 2024 (Q3 2024). The average annual Gross margin for BeiGene, Ltd. have been 1.5% over the past three years, and (78.3%) over the past five years.

2) Is BeiGene, Ltd.'s Gross margin Good?

As of today, BeiGene, Ltd.'s Gross margin is 83.1%, which is higher than industry median of 66.6%. It indicates that BeiGene, Ltd.'s Gross margin is Good.

3) How does BeiGene, Ltd.'s Gross margin compare to its peers?

As of today, BeiGene, Ltd.'s Gross margin is 83.1%, which is lower than peer median of 86.4%. The list of peers includes SMMT, INCY, UTHR, ARGX, REGN, VRTX, ALNY, NVO, BNTX, RPRX.